EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity
Therapeutic modification seen for 16 percent of patients with immune effector cell-associated neurotoxicity syndrome undergoing EEG
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.